Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ELMDNASDAQ:MBOTNYSE:NVRONASDAQ:PROF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeELMDElectromed$23.48+0.6%$28.97$13.74▼$35.56$200.88M0.4166,528 shs20,469 shsMBOTMicrobot Medical$1.48+1.1%$1.74$0.82▼$3.38$51.25M1.61.77 million shs145,803 shsNVRONevro$5.85+0.1%$5.56$3.17▼$14.43$224.28M0.94735,423 shs419,545 shsPROFProfound Medical$6.00-0.9%$6.78$4.75▼$11.42$180.09M0.7853,523 shs29,354 shsUnlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceELMDElectromed0.00%-5.62%-13.68%-22.61%+44.52%MBOTMicrobot Medical0.00%-14.12%+3.55%+23.73%+18.70%NVRONevro0.00%+1.21%+2.10%+57.12%-59.52%PROFProfound Medical0.00%-11.16%-12.70%-14.18%-29.07%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationELMDElectromed1.2344 of 5 stars2.00.00.00.03.92.50.0MBOTMicrobot Medical1.6249 of 5 stars3.52.00.00.01.70.00.6NVRONevro0.9204 of 5 stars1.05.00.00.01.31.70.6PROFProfound Medical2.3222 of 5 stars3.72.00.00.03.00.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceELMDElectromed 4.00Strong Buy$38.0061.87% UpsideMBOTMicrobot Medical 3.00Buy$9.00509.76% UpsideNVRONevro 1.92Reduce$6.439.92% UpsidePROFProfound Medical 3.33Buy$14.25137.70% UpsideCurrent Analyst Ratings BreakdownLatest MBOT, NVRO, ELMD, and PROF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/20/2025ELMDElectromedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$38.002/19/2025ELMDElectromedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy2/10/2025NVRONevroJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderperform ➝ Hold$4.50 ➝ $5.852/7/2025NVRONevroCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$4.00 ➝ $5.852/7/2025NVRONevroPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Overweight$6.00 ➝ $5.851/24/2025MBOTMicrobot MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.00 ➝ $9.00(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookELMDElectromed$59.63M3.37$0.57 per share41.36$5.10 per share4.60MBOTMicrobot MedicalN/AN/AN/AN/A$0.38 per shareN/ANVRONevro$408.52M0.55N/AN/A$8.10 per share0.72PROFProfound Medical$10.68M16.86N/AN/A$1.28 per share4.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateELMDElectromed$5.15M$0.7531.30∞N/A11.34%15.71%13.37%N/AMBOTMicrobot Medical-$10.74M-$0.74N/AN/AN/AN/A-218.30%-158.17%5/13/2025 (Estimated)NVRONevro-$92.21M-$3.05N/AN/AN/A-16.54%-23.52%-10.83%5/6/2025 (Estimated)PROFProfound Medical-$28.57M-$1.12N/AN/AN/A-349.41%-85.22%-64.87%5/8/2025 (Estimated)Latest MBOT, NVRO, ELMD, and PROF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/26/2025Q4 2024MBOTMicrobot Medical-$0.18-$0.20-$0.02-$0.20N/AN/A3/6/2025Q4 2024PROFProfound Medical-$0.31-$0.20+$0.11-$0.20$5.92 million$4.18 million3/4/2025Q4 2024NVRONevro-$0.79-$0.64+$0.15-$1.41$102.61 million$105.55 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthELMDElectromedN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/ANVRONevroN/AN/AN/AN/AN/APROFProfound MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioELMDElectromedN/A5.104.74MBOTMicrobot MedicalN/A3.643.64NVRONevro0.675.023.76PROFProfound Medical0.116.125.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipELMDElectromed40.82%MBOTMicrobot Medical16.30%NVRONevro95.52%PROFProfound Medical47.86%Insider OwnershipCompanyInsider OwnershipELMDElectromed14.00%MBOTMicrobot Medical5.42%NVRONevro3.20%PROFProfound Medical1.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableELMDElectromed1608.56 million7.36 millionOptionableMBOTMicrobot Medical2034.74 million25.64 millionOptionableNVRONevro1,21538.37 million36.27 millionOptionablePROFProfound Medical15030.04 million29.58 millionOptionableMBOT, NVRO, ELMD, and PROF HeadlinesRecent News About These CompaniesBronstein, Gewirtz & Grossman, LLC Encourages Profound Medical Corp. (PROF) Stockholders to Inquire about Securities InvestigationMarch 31 at 10:00 AM | accessnewswire.comIs TULSA-PRO Covered by Medicare?March 30 at 11:14 PM | aol.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Profound Medical Corp. (PROF) and Encourages Investors to Learn More About the InvestigationMarch 30 at 10:00 AM | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Profound Medical Corp. (PROF) and Encourages Stockholders to Learn More About the InvestigationMarch 28 at 10:00 AM | accessnewswire.comKuriakose: Slashed medical research funding has put lives at riskMarch 27, 2025 | detroitnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMarch 27, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Profound Medical Corp. (PROF) Investors to Inquire about Securities InvestigationMarch 27, 2025 | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMarch 27, 2025 | accessnewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities lawsMarch 26, 2025 | investing.comWolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities lawsMarch 26, 2025 | globenewswire.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Profound Medical Corp. (PROF) And Encourages Investors to Reach OutMarch 26, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Profound Medical Corp. (PROF) And Encourages Stockholders to Reach OutMarch 25, 2025 | accessnewswire.comSave the Date: Profound Medical to Host Investor Event at AUA 2025March 25, 2025 | financialpost.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMarch 24, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Profound Medical Corp. (PROF) And Encourages Stockholders to ConnectMarch 24, 2025 | accessnewswire.comRaymond James Financial Inc. Acquires Shares of 875,709 Profound Medical Corp. (NASDAQ:PROF)March 24, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMarch 23, 2025 | accessnewswire.comRosalind Advisors Inc. Has $5.20 Million Stake in Profound Medical Corp. (NASDAQ:PROF)March 23, 2025 | marketbeat.comMagnetar Financial LLC Makes New $3.83 Million Investment in Profound Medical Corp. (NASDAQ:PROF)March 22, 2025 | marketbeat.comPROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law FirmMarch 21, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMarch 21, 2025 | accessnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMBOT, NVRO, ELMD, and PROF Company DescriptionsElectromed NYSE:ELMD$23.48 +0.14 (+0.58%) As of 10:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Microbot Medical NASDAQ:MBOT$1.48 +0.02 (+1.10%) As of 10:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Nevro NYSE:NVRO$5.84 +0.01 (+0.09%) As of 10:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.Profound Medical NASDAQ:PROF$6.00 -0.06 (-0.91%) As of 10:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/24 - 03/28 JPMorgan: The 'NVIDIA of Banking' Poised for More Gains? Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback Joby Aviation Stock: Analyst Confidence and Smart Money Align Get Paid With Paychex: Dividends and Higher Prices Too Ibotta Stock: Why the Buyback Looks Like a Bullish Bet Archer Aviation Stock Sees Surge in Institutional Buys Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
